Increased RANKL/OPG mRNA Ratio in Iliac Bone Biopsies From Women with Hip Fractures
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
RANKL (receptor activator of NF-kappaB) is a potent physiological inducer of osteoclastogenesis. Its actions are blocked by the decoy receptor osteoprotegerin (OPG), and treatment with OPG blocks bone resorption in postmenopausal women. Both positive and negative associations between serum OPG and bone mineral density (BMD) have been reported in the literature. We hypothesized that decreased OPG production relative to RANKL within bone itself could lead to increased risk of osteoporotic fracture. We included ten women with hip fracture (age 76.3 +/- 8.0 years, N.S, : hip BMD 0.686 +/- 1.3 g/cm2, P < 0.05) and 24 women with osteoarthrosis of the hip (age 72.8 +/- 7.2 years, hip BMD 0.832 +/- 1.1 g/cm(2)). Transiliac biopsies were obtained at the time of surgery. Total RNA was extracted from biopsies and reverse-transcribed. Real-time quantification of mRNA was performed with a SYBR Green I real time PCR assay, calculating relative gene expression with normalization of results for beta actin mRNA. Actin normalized mRNA levels for OPG and interleukin (IL)-6 were significantly lower in fracture patients, with a significantly higher RANKL/OPG ratio in patients with fractures. There was no significant difference in tumor necrosis factor (TNF), IL-1, IL-1ra, or IL-7 expression. IL-6 mRNA levels were lower in fracture patients (P < 0.05). The effect of increased RANKL/OPG ratio (Z = 2.08, P < 0.05) on fracture risk was additive to that of hip BMD T score (Z = -1.95, P < 0.05) when assessed using logistic regression. Elderly women with hip fractures exhibit an increased RANKL/OPG mRNA content of iliac bone. This is associated with increased fracture susceptibility, which is not in itself explained by low BMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, the RANKL/OPG mRNA ratio in transiliac bone biopsies of women sustaining a hip fracture was increased compared with controls with osteoarthritis (387).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [387]
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709
Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201 · cited 1×
“Osteoprotegerin (OPG) is the corresponding decoy receptor, which acts as a competitive inhibitor of RANKL action [6, 7].”
BackgroundIL-6 is produced by osteoblasts and induces bone resorption.
Ishimi, Y., Miyaura, C., Jin, C. H., Akatsu, T., Abe, E., Nakamura, Y., Yamaguchi, A., Yoshiki, S., Matsuda, T., Hirano, T., et al. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3297 · Cited by 1,128
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 825
Role of RANK ligand in mediating increased bone resorption in early postmenopausal women
Eghbali-Fatourechi, G., Khosla, S., Sanyal, A., Boyle, W. J., Lacey, D. L., & Riggs, B. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17215 · Cited by 825 · cited 1×
“In accordance with this, a positive correlation has been reported between bone resorption markers and the extent of RANKL expression on the surface of bone marrow cells in postmenopausal women [5].”
BackgroundHofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., & Khosla, S. (1999) · Endocrinology · doi:10.1210/endo.140.10.7034 · Cited by 794
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., & Costantini, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06368.x · Cited by 749
Research works printed but not linked: 2
- WS Browner, 2001, J Clin Endocrinol Metab, 86, 63l
- P Bordier, 1964, Pathol Microbiol, 12, 1238
Cited by
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
Lacey, D. L., Boyle, W. J., Simonet, W. S., Kostenuik, P. J., Dougall, W. C., Sullivan, J. K., Martin, J. S., & Dansey, R. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3705 · Cited by 694
Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength.
KOSTENUIK, P. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.06.005 · Cited by 281
Seriwatanachai, D., Thongchote, K., Charoenphandhu, N., Pandaranandaka, J., Tudpor, K., Teerapornpuntakit, J., Suthiphongchai, T., & Krishnamra, N. (2008) · Bone · doi:10.1016/j.bone.2007.11.008 · Cited by 175
Rauner, M., Sipos, W., & Pietschmann, P. (2007) · International Archives of Allergy and Immunology · doi:10.1159/000098223 · Cited by 132
RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases
Baud’huin, M., Lamoureux, F., Duplomb, L., Rédini, F., & Heymann, D. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7104-0 · Cited by 170
Expression of bone resorption genes in osteoarthritis and in osteoporosis
Logar, D. B., Komadina, R., Preželj, J., Ostanek, B., Trošt, Z., & Marc, J. (2007) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0753-0 · Cited by 164
Gene expression profile of the bone microenvironment in human fragility fracture bone
Hopwood, B., Tsykin, A., Findlay, D. M., & Fazzalari, N. L. (2008) · Bone · doi:10.1016/j.bone.2008.08.120 · Cited by 126
Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis
Jabbar, S., Drury, J., Fordham, J. N., Datta, H. K., Francis, R. M., & Tuck, S. P. (2011) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.086595 · Cited by 107
Effect of Age on Regulation of Human Osteoclast Differentiation
Chung, P., Zhou, S., Eslami, B., Shen, L., LeBoff, M. S., & Glowacki, J. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24792 · Cited by 117
Ramani, V. C., Yang, Y., Ren, Y., Nan, L., & Sanderson, R. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.183277 · Cited by 115
Gibellini, D., Borderi, M., Crignis, E. D., Cicola, R., Vescini, F., Caudarella, R., Chiodo, F., & Re, M. C. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20938 · Cited by 114
Temporal pattern of gene expression and histology of stress fracture healing
Kidd, L. J., Stephens, A. S., Kuliwaba, J. S., Fazzalari, N. L., Wu, A., & Forwood, M. R. (2009) · Bone · doi:10.1016/j.bone.2009.10.009 · Cited by 107
Sheng, R., Cao, M., Song, M., Wang, M., Zhang, Y., Shi, L., Xie, T., Li, Y., Wang, J., & Rui, Y. (2023) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2023.09.007 · Cited by 91
Dengue virus entry into liver (HepG2) cells is independent of hsp90 and hsp70
Cabrera‐Hernandez, A., Thepparit, C., Suksanpaisan, L., & Smith, D. R. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20786 · Cited by 87
Azizieh, F. Y., Shehab, D., Al-Jarallah, K. F., Gupta, R., & Raghupathy, R. (2019) · Biomarker Insights · doi:10.1177/1177271919843825 · Cited by 79
Dobnig, H., Hofbauer, L. C., Viereck, V., Obermayer-Pietsch, B., & Fahrleitner-Pammer, A. (2006) · Osteoporosis International · doi:10.1007/s00198-005-0035-4 · Cited by 76
“In various cross-sectional studies, measurements of serum OPG levels have been found to be either correlated [18, 19] or not correlated [20, 21] to bone density, whereas the local expression of OPG mRNA levels in iliac bone biopsies has been correlated with increased fracture susceptibility [22].”
BackgroundYang, Y., Ren, Y., Ramani, V. C., Nan, L., Suva, L. J., & Sanderson, R. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2179 · Cited by 66
Role of the RANK/RANKL pathway in breast cancer
Kiesel, L., & Kohl, A. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.01.001 · Cited by 68
Efficacy and safety of currently marketed anti-osteoporosis medications
Reginster, J., Neuprez, A., Dardenne, N., Beaudart, C., Emonts, P., & Bruyère, O. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.09.003 · Cited by 65
Corrado, A., Neve, A., Macchiarola, A., Gaudio, A., Marucci, A., & Cantatore, F. P. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.120845 · Cited by 62
Infection of human primary hepatocytes with dengue virus serotype 2
Suksanpaisan, L., Cabrera‐Hernandez, A., & Smith, D. R. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20798 · Cited by 62
Mundy, G. R., Oyajobi, B. O., Gutierrez, G. E., Sterling, J. A. R., Padalecki, S. S., Elefteriou, F., & Zhao, M. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50020-3 · Cited by 61
Tiyasatkulkovit, W., Charoenphandhu, N., Wongdee, K., Thongbunchoo, J., Krishnamra, N., & Malaivijitnond, S. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.07.010 · Cited by 58
Seriwatanachai, D., Charoenphandhu, N., Suthiphongchai, T., & Krishnamra, N. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2008.04.026 · Cited by 50
Giner, M., Rios, M. J., Montoya, M. J., Vázquez, M. Á., Naji, L., & Pérez‐Cano, R. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.11.005 · Cited by 47
Dragojevič, J., Zupan, J., Haring, G., Herman, S., Komadina, R., & Marc, J. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0445-x · Cited by 47
Patsch, J., Kohler, T., Berzlanovich, A. M., Muschitz, C., Bieglmayr, C., Roschger, P., Resch, H., & Pietschmann, P. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.344 · Cited by 45
Xie, W., Li, F., Han, Y., Qin, Y., Wang, Y., Chi, X., Xiao, J., & Li, Z. (2020) · Aging · doi:10.18632/aging.103129 · Cited by 40
Developments in the pharmacotherapeutic management of osteoporosis
Close, P., Neuprez, A., & Reginster, J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.12.1603 · Cited by 40
WANG, X.-F., Zhang, Y., YU, Z.-S., & Zhou, J. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1335 · Cited by 37
Park, K., Park, J.-I., Lee, S., Yoo, K., Kweon, G., Kwon, I. K., Yun, H., & Hong, J. T. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106423 · Cited by 35
Charoenphandhu, N., Teerapornpuntakit, J., Methawasin, M., Wongdee, K., Thongchote, K., & Krishnamra, N. (2008) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y08-037 · Cited by 33
Skeletal deterioration induced by RANKL infusion: a model for high-turnover bone disease
Yuan, Y. Y., Kostenuik, P. J., Ominsky, M. S., Morony, S., Adamu, S., Simionescu, D. T., Basalyga, D. M., Asuncion, F., & Bateman, T. A. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0509-7 · Cited by 33
Expression of RANKL in Osteolytic Membranes: Association with Fibroblastic Cell Markers
Ramage, S., Urban, N. H., Jiranek, W. A., Maiti, A., & Beckman, M. J. (2007) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200704000-00021 · Cited by 31
Reginster, J. Y., Neuprez, A., Beaudart, C., Lecart, M. P., Sarlet, N., Bernard, D., Disteche, S., & Bruyere, O. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0179-z · Cited by 29
Molecular mechanisms of osteoporotic hip fractures in elderly women
Föger‐Samwald, U., Vekszler, G., Hörz-Schuch, E., Salem, S., Wipperich, M., Ritschl, P., Mousavi, M., & Pietschmann, P. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.11.012 · Cited by 28
Osteoimmunopathology in HIV/AIDS: A Translational Evidence-Based Perspective
Barkhordarian, A., Ajaj, R. A., Ramchandani, M. H., Demerjian, G. G., Cayabyab, R., Danaie, S., Ghodousi, N., Iyer, N., Mahanian, N., Phi, L., et al. (2011) · Pathology Research International · doi:10.4061/2011/359242 · Cited by 26
Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts
Lee, D.-W., Kwon, J.-Y., Kim, H.-K., Lee, H. J., Kim, E., Kim, H. J., Kim, H. J., & Lee, H.-B. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.22713 · Cited by 26
The Impact of Chronic Inflammation on Bone Turnover in Hemodialysis Patients
Eleftheriadis, T., Kartsios, C., Antoniadi, G., Kazila, P., Dimitriadou, M., Sotiriadou, E., Koltsida, M., Golfinopoulos, S., Liakopoulos, V., & Apostolaki-Christopoulou, M. (2008) · Renal Failure · doi:10.1080/08860220801964251 · Cited by 26
Are OPG and RANKL involved in human fracture healing?
Starlinger, J., Thomas, A., Gregori, M., Kecht, M., Kaiser, G., Eipeldauer, S., & Sarahrudi, K. (2014) · Journal of Orthopaedic Research® · doi:10.1002/jor.22723 · Cited by 27
Molecular evidence of osteoblast dysfunction in elderly men with osteoporotic hip fractures
Föger‐Samwald, U., Patsch, J., Schamall, D., Afarin, A., Deutschmann, J., Salem, S., Mousavi, M., & Pietschmann, P. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.05.014 · Cited by 23
Can hip fracture prediction in women be estimated beyond bone mineral density measurement alone?
Geusens, P., van Geel, T. A. C. M., & van den Bergh, J. P. (2010) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x09359541 · Cited by 23
Evans, C., Mylchreest, S., & Andrew, J. (2006) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-7-21 · Cited by 21
Eriksen, C. G., Olsen, H., Husted, L. B., Sørensen, L., Carstens, M., Søballé, K., & Langdahl, B. L. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9412-x · Cited by 20
Neuroimmune expression in hip osteoarthritis: a systematic review
da Silva, M. R., Linhares, D., Vasconcelos, D. M., Alves, C. J., Nevès, N., Costa, G., & Lamghari, M. (2017) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-017-1755-2 · Cited by 17
REN, H., REN, H., LI, X., YU, D., MU, S., CHEN, Z., & FU, Q. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4328 · Cited by 14
Charoenphandhu, N., Suntornsaratoon, P., Jongwattanapisan, P., Wongdee, K., & Krishnamra, N. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00242.2012 · Cited by 13
Effect of turmeric extract on bone healing in an experimental model of femoral bone fracture
Ilka (2022) · PubMed · doi:10.22038/ajp.2021.18561 · Cited by 7
“Therefore, the RANKL to OPG ratio (RANKL/OPG) determines the status of osteoclast function and bone metabolism (Gravallese et al., 2000; Abdallah et al., 2005; Lee et al., 2018).”
BackgroundFichna, M., Żurawek, M., Fichna, P., Gryczyńska, M., Nowak, J., & Ruchała, M. (2012) · PubMed · Cited by 6
Ethanol extract of Cyathulae Radix inhibits osteoclast differentiation and bone loss
Liying, S. H. I., Liuyi, R. E. N., Li, J., Liu, X., Jingjing, L. U., Lujuan, J. I. A., Baoping, X. I. E., Tang, S., Liu, W., & Zhang, J. (2024) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(24)60596-0 · Cited by 6
Time dependent loss of trabecular bone in human tibial plateau fractures
Solomon, L. B., Kitchen, D. S., Anderson, P., Yang, D., Starczak, Y., Kogawa, M., Perilli, E., Smitham, P. J., Rickman, M. S., Thewlis, D., et al. (2018) · Journal of Orthopaedic Research® · doi:10.1002/jor.24057 · Cited by 5
Osteoimmunological Insight in to Vertebral Fractures in Osteoporosis
Saghafi, H., Hossein‐Nezhad, A., Sedighi, N., Tofighi, P., Soltani, A., Larijani, B. A., & Hafezi, R. (2008) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
Мироманов, А. М., Аркадьевич, Г. К., Николаевич, С. А., Миронова, О. Б., & Анатольевна, М. Н. (2022) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2022-7.2.6 · Cited by 3
Pathophysiology and Aging of Bone
Pietschmann, P., Gruber, R., & Peterlik, M. (2008) · Medical radiology · doi:10.1007/978-3-540-68604-0_2 · Cited by 3
Vaňuga, P., & Ságová, I. (2021) · Vnitřní lékařství · doi:10.36290/vnl.2021.073 · Cited by 2
Mundy, G. R., Oyajobi, B. O., Gutierrez, G., Sterling, J. A. R., Padalecki, S. S., Elefteriou, F., & Zhao, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50019-6 · Cited by 1
The differential effects of two critical osteoclastogenesis stimulating factors on bone biomechanics
Yuan, Y. (2007) · TigerPrints (Clemson University) · Cited by 1
Gene expression analyses for osteoporosis research
Pietschmann, P., & Föger‐Samwald, U. (2013) · Osteologie/Osteology · doi:10.1055/s-0038-1630101
da Silva, R. A. (2011) · Journal of Computational Interdisciplinary Sciences · doi:10.6062/jcis.2011.02.03.0042
Untersuchung von Signalwegen in Rattenmodellen mit unterschiedlichen Knochenheilungsstörungen
Minkwitz, S. (2015) · DepositOnce · doi:10.14279/depositonce-4535
Carmody, E. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-66572-6_21
Chiappelli, F. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9495-0_2
Rosch, S., & Justus Liebig University Giessen (2020) · University writing server of the Justus Liebig University Giessen (Justus-Liebig-Universität Gießen) · doi:10.22029/jlupub-14804
Metadata
- Authors
- Abdallah, B. M., Stilgren, L. S., Nissen, N., Kassem, M., Jørgensen, H. R. I., & Abrahamsen, B.
- Affiliations
- Odense University Hospital (DK)
- Corresponding author
- Abrahamsen, Bo
- Venue
- Calcified Tissue International
- Published
- 2004-11-18
- Volume
- 76
- Issue
- 2
- Pages
- 90-97
- ISSN
- 0171-967X (ISSN-L)
- 1432-0827
- OpenAlex
- W2033504273
- Cited by
- 60
- References
- 41
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 5 · 2013: 4 · 2012: 4
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Calcified Tissue International (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- RANKL/OPG ratio, osteoprotegerin, RANKL, hip fracture, osteoporotic fractures, iliac bone biopsy, interleukin-6, bone mineral density, postmenopausal women, osteoclastogenesis, fracture risk, older women
- MeSH terms
- Aged, Aged, 80 and over, Biopsy, Carrier Proteins, Female, Hip Fractures, Humans, Ilium, Membrane Glycoproteins, Middle Aged, RNA, Messenger, Biomarkers, Absorptiometry, Photon, Bone Density, Interleukin-6, Gene Expression, Cytokines, DNA Primers, Reverse Transcriptase Polymerase Chain Reaction, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.